Eligibility

Privacy:

Your privacy is important to us. Aruvant will use your personal information only for purposes of providing you information about the MOMENTUM Study and other Aruvant studies and facilitating your potential enrollment into the MOMENTUM Study and other Aruvant studies.

Sign up to learn more about the MOMENTUM Study - a Sickle Cell clinical trial.

If you wish to be considered for participation in the MOMENTUM Study or other Aruvant studies (the “Aruvant Studies”), select either yes or no below. If you select yes, your contact information will be shared with Aruvant’s partners and affiliates, including our Patient Navigator and clinical trial study sites. Our Patient Navigator may contact you via phone or email to answer your questions and determine your interest and possible eligibility for the Aruvant Studies. Your personal information, including information entered above and discussed with the Patient Navigator, may then be forwarded to a clinical study site. Your privacy is important to us. Aruvant will use your personal information only for purposes of providing you information about the Aruvant Studies and facilitating your potential enrollment into the Aruvant Studies. Aruvant will share your personal information with our Patient Navigator (a representative of Aruvant) and clinical study sites to help you determine your eligibility for the Aruvant Studies. Aruvant will act solely on its own behalf and not perform recruitment on behalf of such clinical study sites. Aruvant will not disclose your personal information with additional parties without your consent unless disclosure is required by the federal agencies (such as FDA) in charge of overseeing clinical studies, or as required by law. You may revoke consent to disclosure and request deletion of your personal information at any time by emailing us at clinicaltrials@aruvant.com. Upon receipt of such request, we will delete (and direct our partners to delete) your personal information from our records, subject to the terms of our Privacy Policy.

Thank you!